Fund profile by ISIN IE000KD0BZ68
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc
Research Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc by ISIN IE000KD0BZ68: TER 0.30%, domicile Ireland, and 1-year price performance +44.5%.
ISINIE000KD0BZ68
TER0.30%
DomicileIreland
Distribution policy—
Index—
Fund size10M
Holdings—
1-year price performance+44.5%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| XGEN.DE | XETRADefault at German brokers | EUR | Ireland | €72K | 2,165 |
| XGEN.MI | ETFP | EUR | Ireland | €14K | 414 |
| XGEN.L | LSE | USD | Ireland | €4K | 127 |
| XGES.L | LSE | GBP | Ireland | €3K | 104 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-08-28.
Largest holdings
The 10 largest holdings make up 43.54% of the fund. As of 2026-08-14.
| Holding | Symbol | Weight |
|---|---|---|
| Natera Inc | NTRA | 5.25% |
| Illumina Inc | ILMN | 4.70% |
| Moderna Inc | MRNA | 4.70% |
| Agilent Technologies Inc | A | 4.55% |
| Vertex Pharmaceuticals Inc | VRTX | 4.33% |
| Danaher Corp | DHR | 4.32% |
| Lonza Group Ltd | LONN.SW | 4.15% |
| GSK PLC ADR | GSK | 3.89% |
| argenx SE ADR | ARGX | 3.86% |
| Guardant Health Inc | GH | 3.78% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.